Alkermes Signs US$950 M Deal with Rodin Therapeutics to Boost CNS Pipeline
By Michelle Liu
Pharma Deals Review: Vol 2019 Issue 11 (Table of Contents)
Published: 22 Nov-2019
DOI: 10.3833/pdr.v2019.i11.2471 ISSN: 1756-7874
Section: Mergers & Acquisitions
Fulltext:
Abstract
In a bid to bolster its CNS pipeline, Alkermes has agreed to acquire Rodin Therapeutics in a deal worth up to US$950 M...
This page is available to subscribers only.
Not a subscriber? Join here
Already Registered? Please login using the top left purple box.
Copyright: © IQVIA 2018
RSS